20 Jul 2020 --- Lallemand Health Solutions will commercialize Proge Farm’s L. plantarum P17630 (Proge P17630) probiotic strain, which can aid in maintaining an equilibrium of a normal vaginal microflora in certain circumstances. The closure of the licensing deal will provide a new asset to Lallemand’s women’s health probiotic range and includes Asia, the Americas, France and Czechia. While oral formulation is now licensed to Lallemand Health Solutions, Proge Farm also proposes Proge P17630 as an active ingredient of medicine for vaginal use in softgel capsules.
